Arrhythmias & electrophysiology

Risk-Guided Atrial Fibrillation Screening With Artificial Intelligence–Enabled Electrocardiogram Models: A VITAL-AF Trial Analysis

J Am Coll CardiolPublished Secondary analysis of the VITAL-AF cluster-randomised trial

Primary result · AF diagnosis rate, top decile of CH-AIResult — go to the resultDifference 2.32 /100 person-years 95% CI 0.01–4.63

Authors' conclusion

Use of ECG-based AI and clinical factors identified individuals at particularly high risk for AF who may benefit from screening.

Study context

Population
Patients aged ≥65 years without prevalent atrial fibrillation (AF) at 16 primary care practices (Massachusetts General Hospital), with a 12-lead electrocardiogram (ECG) within 3 years before enrollmentof 30,630 without prevalent AF
Participants
16,937 patients
Comparison
AF screening with single-lead ECG vs control, across AI-ECG and clinical AF risk deciles
Primary endpoint
AF screening effect: difference in incident AF diagnosis rate (per 100 person-years), screening vs control, across AF risk deciles
Follow-up
2 years
Methodological detailscluster-randomized, 16 primary care practices
  • Cluster-randomized
  • 16 primary care practices

Primary result

AF diagnosis rate, top decile of CH-AI

Difference

2.32 /100 person-years

95% CI 0.01–4.63

P < 0.05

By group

Screeningvs Control
difference 2.32 /100 person-years (95% CI 0.01–4.63); P < 0.05

As reported in the abstract

Further findings

OutcomeCHARGE-AFECG-AICH-AI
Discrimination of 2-year AF risk (AUROC; average precision)
AUROC0.711 (95% CI 0.671-0.749)0.784 (95% CI 0.743-0.819)0.788 (95% CI 0.754-0.824)
Average precision0.0952 (95% CI 0.0836-0.112)0.132 (95% CI 0.113-0.157)0.133 (95% CI 0.117-0.159)
  • Discrimination of 2-year AF risk (AUROC; average precision): Cohorts of Heart and Aging Research in Genomic Epidemiology-AF (CHARGE-AF) clinical score; ECG-AI = artificial intelligence (AI) model on 12-lead ECG alone; CH-AI = ECG-AI combined with CHARGE-AF

Original publication

Risk-Guided Atrial Fibrillation Screening With Artificial Intelligence–Enabled Electrocardiogram Models: A VITAL-AF Trial Analysis. J Am Coll Cardiol. Published 14 April 2026. doi:10.1016/j.jacc.2026.01.087

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.